Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (151-160 of 337) with videos related to

Pageof 34
Sort By:
Acta Neuropathologica Communications|July 27, 2023
Mitochondrial DNA mutations in MedulloblastomaViktoria L E Funke, Sarah Sandmann, Viktoria Melcher, et al.
BMC Cancer|April 5, 2023
The potential of PARP as a therapeutic target across pediatric solid malignanciesKaylee M Keller, Joost Koetsier, Linda Schild, et al.
Acta Neuropathologica|April 5, 2019
Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1Christian Thomas, Friederike Knerlich-Lukoschus, Harald Reinhard, et al.
Acta Neuropathologica|July 14, 2023
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomicsPascal D Johann, Lea Altendorf, Emma-Maria Efremova, et al.
Acta Neuropathologica|February 14, 2018
Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activationJ Bryan Iorgulescu, Jessica Van Ziffle, Meredith Stevers, et al.
The American Journal of Surgical Pathology|January 12, 2018
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC SubgroupPascal D Johann, Susanne Bens, Florian Oyen, et al.
Acta Neuropathologica|March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersAndrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Journal of Translational Medicine|June 5, 2023
Group-specific cellular metabolism in MedulloblastomaViktoria L E Funke, Carolin Walter, Viktoria Melcher, et al.
Cell Reports|August 25, 2021
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumorsCamilla Calandrini, Sander R van Hooff, Irene Paassen, et al.
Acta Neuropathologica|April 5, 2014
Subgroup-specific localization of human medulloblastoma based on pre-operative MRIAnnika K Wefers, Monika Warmuth-Metz, Julia Pöschl, et al.
Pageof 34

Showing results (151-160 of 337) with videos related to

Sort By:
Pageof 34
Acta Neuropathologica Communications|July 27, 2023
Mitochondrial DNA mutations in MedulloblastomaViktoria L E Funke, Sarah Sandmann, Viktoria Melcher, et al.
BMC Cancer|April 5, 2023
The potential of PARP as a therapeutic target across pediatric solid malignanciesKaylee M Keller, Joost Koetsier, Linda Schild, et al.
Acta Neuropathologica|April 5, 2019
Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1Christian Thomas, Friederike Knerlich-Lukoschus, Harald Reinhard, et al.
Acta Neuropathologica|July 14, 2023
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomicsPascal D Johann, Lea Altendorf, Emma-Maria Efremova, et al.
Acta Neuropathologica|February 14, 2018
Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activationJ Bryan Iorgulescu, Jessica Van Ziffle, Meredith Stevers, et al.
The American Journal of Surgical Pathology|January 12, 2018
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC SubgroupPascal D Johann, Susanne Bens, Florian Oyen, et al.
Acta Neuropathologica|March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersAndrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Journal of Translational Medicine|June 5, 2023
Group-specific cellular metabolism in MedulloblastomaViktoria L E Funke, Carolin Walter, Viktoria Melcher, et al.
Cell Reports|August 25, 2021
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumorsCamilla Calandrini, Sander R van Hooff, Irene Paassen, et al.
Acta Neuropathologica|April 5, 2014
Subgroup-specific localization of human medulloblastoma based on pre-operative MRIAnnika K Wefers, Monika Warmuth-Metz, Julia Pöschl, et al.
Pageof 34